Cancer-associated myasthenic (Eaton-Lambert) syndrome: distribution of abnormality and effect of treatment.
Treatment with plasma exchange, steroids, immunosuppressant drugs and cytotoxic chemotherapy was effective in two cases of cancer-associated Eaton-Lambert myasthenic syndrome. The clinical improvement noted during treatment was accompanied by improvement in the electrophysiological abnormality; this was much more marked in abductor digiti minimi and trapezius than in extensor digitorum brevis.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000150:complications* / Q000188:drug therapy; D003131:Combined Modality Therapy; D004576:Electromyography; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000175:diagnosis* / Q000628:therapy; D010951:Plasma Exchange; D011239:Prednisolone / Q000627:therapeutic use
D011239:Prednisolone